News

Patients with active cancer and newly diagnosed isolated distal deep vein thrombosis (DVT) who received 12 months of edoxaban (Savaysa) had fewer thrombotic events at 1 year than those who received 3 months of treatment, without significantly increased bleeding, in the ONCO-DVT trial.   However, lead author Yugo Yamashita, MD, from Kyoto University, Japan, notes
0 Comments
Bronchiectasis was associated with an increased mortality risk in current and former smokers even if they did not meet the spirometric criteria for chronic obstructive pulmonary disease (COPD), an observational study found. Compared with patients without suspected bronchiectasis, the 10-year mortality risk was greater among patients who had suspected bronchiectasis — evidenced by CT and
0 Comments
When the last few months of the year get hectic with holiday festivities, your taxes might be the last thing on your mind. But thinking about your taxes — and possibly making some money-related changes — before the new year can make a big difference when it comes to how much you owe to (or
0 Comments
Postoperative parathyroid hormone (PTH) showed 100% sensitivity in predicting post-thyroidectomy hypocalcemia, according to the results of a prospective study of 60 patients. Post-thyroidectomy hypocalcemia remains a major complication in patients who have undergone total thyroidectomy, and early identification can reduce disease burden and improve outcomes, according to Ahmed Sobhy Youssef, MD, of the University of
0 Comments
Cardiac problems, including heart attacks, are no longer limited to older adults. With changing lifestyles, dietary habits and increased stress levels, young adults are also susceptible. On this World Heart Day (Sept. 29), let’s understand the risk factors associated with cardiac issues in young adults and listen to expert opinions for prevention. Cardiovascular disease, a
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. If you’re having trouble getting the latest COVID-19 booster, you’re not alone. As the rollout of the newly formulated shot begins in earnest, many Americans are finding roadblocks, while federal officials urge everyone to be patient and get the shot when
0 Comments
Hot flashes and night sweats, the discomforting symptoms often linked to menopause, can have effects beyond disrupted sleep. A new study has found that women who experience hot flashes during sleep are at a higher risk of Alzheimer’s. Alzheimer’s is a progressive brain disorder that affects memory, thinking and behavior. More than 6.5 million people
0 Comments
The US Food and Drug Administration (FDA) has approved the biosimilar tocilizumab-bavi (Tofidence), Biogen, the drug’s manufacturer, announced today. It is the first tocilizumab biosimilar approved by the FDA. The reference product, Actemra (Genentech), was first approved by the agency in 2010. “The approval of Tofidence in the U.S. marks another positive step toward helping
0 Comments
The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted daily, but keeping up can be a challenge. As an aid for our readers, and for a little amusement, here is a 10-question quiz based on the news of the
0 Comments
Suffering from chronic back pain? Researchers say a brain-based treatment could be effective in reducing its severity. People experience pain for various reasons, but there are instances wherein some experience physical pain without any definite cause. In such cases, managing one’s perspective about the brain’s role in chronic pain could help them deal with it
0 Comments
LONDON (Reuters) – Philip Morris International (PMI) on Thursday unveiled a zero-tobacco stick for use with its “heat-not-burn” device IQOS, which may help the company avoid tax and other regulations that affect its tobacco products in some markets. IQOS heats up small packets of ground up tobacco resembling cigarettes but does not burn them, a
0 Comments
PHILADELPHIA — Fezolinetant (Veozah) improved menopause-related vasomotor symptoms in women unsuited or unwilling to take hormone therapy, according to a pooled analysis of two phase III studies. The analysis of the SKYLIGHT-1 and -2 trials showed significant improvements with two different dosages of the newly approved drug versus placebo in both the frequency and severity
0 Comments
TOPLINE: Vegetarian diets may reduce the risk for gastric and colorectal cancers, according to the results of a meta-analysis. METHODOLOGY: Researchers did a systematic review and meta-analysis of seven original studies (six cohorts and one case-control) involving 686,691 people. Pooled relative risk (RR) for gastric, colorectal, and upper gastrointestinal (GI) cancers were assessed with confidence
0 Comments
The risk for inflammatory bowel disease (IBD) was increased among children and adults with atopic dermatitis (AD), with the risk increasing with AD severity, according to data from a large cohort study published recently in JAMA Dermatology. The study also found an increased risk for Crohn’s disease (CD) in adults and children with AD, as
0 Comments
The Occupational Safety and Health Administration (OSHA) came in for blistering criticism from House Republicans at a hearing Wednesday, as Democrats defended the agency’s work in the face of underfunding. Rep. Kevin Kiley (R-Calif.), chairman of the House Education & the Workforce Committee’s Workforce Protections Subcommittee, started the hearing by mentioning that OSHA head Douglas
0 Comments
Smoking, a major factor that contributes to indoor air pollution, is known to cause health issues like respiratory infections, asthma attacks and lung cancer in children. But what about emissions from the cooking stove? A new study has revealed a link between exposure to unclean cooking fuels and development delays in children. Clean fuel refers
0 Comments
TOPLINE: A Pap smear result indicating cervical dysplasia may actually be an early signal of genitourinary syndrome (vaginal atrophy) and can be treated effectively with local estrogen, according to a poster presented at The 2023 Menopause Meeting of the North American Menopause Society. METHODOLOGY: Starting in 2010, researchers in Florida and Antigua saw an increase
0 Comments
After multiple prior rejections, gepirone hydrochloride extended-release (ER; Exxua) gained FDA approval for the treatment of major depressive disorder (MDD) in adults, drugmaker Fabre-Kramer Pharmaceuticals announced. Gepirone ER is the first approved antidepressant that selectively targets the serotonin 1A receptor, which regulates mood and emotion. The drug was approved based on data from two 8-week
0 Comments
An experimental stem cell therapy for the treatment of mild to moderate amyotrophic lateral sclerosis (ALS) received a resounding rejection today from a US Food and Drug Association (FDA) advisory panel that cited efficacy, safety and product manufacturing concerns. The 17-1 vote (with one abstention) against approval by members of the FDA’s Peripheral and Central
0 Comments